Julab

Julab

selegiline

Manufacturer:

Biolab

Distributor:

Biopharm
Concise Prescribing Info
Contents
Selegiline HCl
Indications/Uses
Adjuvant to levodopa, or levodopa & peripheral decarboxylase inhibitor therapy in parkinsonism.
Dosage/Direction for Use
5-10 mg daily.
Administration
Should be taken with food.
Contraindications
Concomitant pethidine, TCA, SSRIs, serotonin agonists eg, sumatriptan. Pregnancy & lactation.
Special Precautions
Peptic ulceration, uncontrolled HTN, arrhythmias, angina, psychosis.
Adverse Reactions
Nausea, dizziness, abdominal pain, confusion, hallucination, dry mouth, increased dyskinesias.
Drug Interactions
Pethidine, TCA, SSRIs, serotonin agonists eg, sumatriptan.
ATC Classification
N04BD01 - selegiline ; Belongs to the class of dopaminergic agents, monoamine oxidase B inhibitors. Used in the management of Parkinson's disease.
Presentation/Packing
Form
Julab tab 5 mg
Packing/Price
5 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in